Post Categories
Meet QPS at the EAACI in Lisbon
May 9, 2019
Professor Zuzana Diamant, EAACI Asthma Section Chair (2017-2019), will chair and lecture at the EAACI (European Academy of Allergy and Clinical Immunology) symposium in…
Meet QPS at the ATS in Dallas
May 9, 2019
Professor Zuzana Diamant, MD PhD, Executive Medical and Scientific Director of Respiratory & Allergy at QPS-NL and Khalid Abd-Elaziz, MD, Principle Investigator, Associate Medical…
DDI Studies: The Final Frontier?
May 9, 2019
QPS recognizes the importance of well-conducted clinical trials on drug-drug interactions. Historically, the CYP450 interactions provided valuable information for the safe use of drugs,…
Challenging the Inhaled Allergen Challenge
May 9, 2019
Presently, the QPS Respiratory Team is making progress on a large data-intensive, 2-centre allergen challenge study in eosinophilic allergic asthma testing an innovative new…
QPS has a Strong Competency in Alzheimer Research
May 9, 2019
The results of a research collaboration between the neuroscience group of QPS Netherlands B.V. and Professor Peter Paul de Deyn and coworkers of the…
QPS will exhibit at the World Vaccine Congress
April 15, 2019
QPS will exhibit at the World Vaccine Congress, April 15-17 in Washington, DC. Please stop by our booth #600 to learn more about QPS’…
BREXIT IMPACT: More Questions Than Answers
March 30, 2019
Later this month the United Kingdom (UK) is expected to achieve independence from the European Union (EU) based on a referendum that was passed…
QPS is exhibiting at the 13th Annual WRIB Meeting
March 27, 2019
QPS is exhibiting at the 13th Annual WRIB Meeting, April 1-4 in New Orleans, LA. If you are attending, please visit us at booth…
QPS will exhibit at the 4th Annual Neuroscience R&D Technologies Conference, October 4-5 in Munich, Germany.
October 4, 2018
QPS will exhibit at the 4th Annual Neuroscience R&D Technologies Conference, October 4-5 in Munich, Germany. Please stop by our Booth #5 to learn…
QPS will exhibit at the 14th International Conference on Alzheimer’s & Parkinson’s Disease
March 26, 2019
QPS will exhibit at the 14th International Conference on Alzheimer’s & Parkinson’s Disease, March 26-31 in Lisbon, Portugal. Please stop by our booth #28…
QPS is exhibiting at the 3rd Annual Gene Therapy for Rare Disorders Conference
March 26, 2019
QPS is exhibiting at the 3rd Annual Gene Therapy for Rare Disorders Conference, between March 26-28 in Boston, MA. If you are attending the…
Spreading Early Clinical Knowledge
October 20, 2017
Shoulder to shoulder with our clients, we at QPS like to share the results of our early clinical research efforts, published in the scientific…
How Ancient Wolves Evolved into Man’s Best Friend
August 29, 2022
If you compare a pack of fearsome ancient wolves with a pack of modern-day chihuahuas, it’s clear that domesticated dogs have evolved almost beyond…
Could Bear Serum Help the Bedridden?
August 22, 2022
Prolonged periods of rest are essential for the sick and those recovering from surgery, but bed rest takes its toll on human bodies. Animal…
Study Finds Norovirus Could Spread Through Saliva
August 17, 2022
Norovirus is the most common cause of acute gastroenteritis, causing an estimated 685 million cases each year. The virus can lead to severe illness…
Hangry Is Officially a Thing. So, What Should We Do About It?
August 8, 2022
In 2018 the word “hangry,” the portmanteau of hungry and angry, was finally added to the Oxford English Dictionary. We say finally because the…
Are Fully Hypoallergenic Cats the Pets of the Future?
August 3, 2022
Pet owners represent a whopping 70 percent of U.S. households, with dogs and cats reigning supreme as the most popular pets. But while cat…
The Japan Model: Limiting the Impact of COVID Without Lockdowns
August 1, 2022
Japan, a country with a population, on average, 10 years older than that of the United States of America, experienced a comparably minimal impact…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
Introduction Changes in how clinical trials are managed in the European Union (EU), mandated by the European Union Clinical Trial Regulation 536/2014 (EU CTR),…
TAIPEI, Taiwan—(BUSINESS WIRE)—QPS, a leading global contract research organization (CRO) specializing in preclinical and clinical drug development services, is pleased to announce the expansion…
QPS India has achieved another significant milestone by successfully completing a scheduled inspection by the UK Medicines and Healthcare products Regulatory Agency (MHRA) from…
QPS Selects Ryght AI as an Exclusive AI Partner for Clinical Trial Optimization and Automation while adding to Ryght’s global site network. Laguna Beach,…
